ClinicalTrials.gg
RecruitingNCT07730086Updated Jul 28, 2026

Smartphone Accelerometry for Gait Analysis in Children With Unilateral Spastic Cerebral Palsy

An observational study in Cerebral Palsy and Unilateral Spastic Cerebral Palsy, sponsored by Deraya University. Recruiting at 1 site in Egypt. Open to participants aged 6 Years to 12 Years. Per ClinicalTrials.gov, last updated 2026-07-28.

Sponsored by Deraya University · Observational

How we know

From the registry’s dates

  • Started Jul 2026; still recruiting 4 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
35
Ages
6 Years to 12 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 159 studies in Cerebral Palsy with a site in Egypt — 40 open to participants now, 52 under way, 2 of them phase 3. Cerebral Palsy · Egypt.

Planned enrollment
21st of 24
35 · median 62
Started
2026
with 19 others
Observational
24 of 159
6 open now
Primary completion
2026-11
later than 45 of 51 live
Registered
149th of 159
by date

Among the 159 studies in Cerebral Palsy with a site in Egypt, this one is the 21st largest by planned enrollment of the 24 observational ones that give a count, is one of 20 that started in 2026, is one of 24 observational ones, reaches primary completion later than 45 of the 51 other live ones, and was the 149th registered.

Cerebral Palsy

1,942 studies on the registry are indexed under Cerebral Palsy; 456 are open to participants now.

Browse Cerebral Palsy studies →

Open to participants now

40 of the 159 studies in Cerebral Palsy with a site in Egypt are open now. Recruiting first, the newest first:

34 more — sign in →

All 40 open studies →

A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →

Who these studies take

Of the 271 Cerebral Palsy studies recruiting now, 26 (10%) set no upper age limit and 237 (87%) stop at 75 or younger; 256 take children under 18; 53 take healthy volunteers.

This study: 6 Years to 12 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 159 studies in Cerebral Palsy with a site in Egypt, or all of them as a file.
02

Study summary

This observational study will evaluate whether a smartphone's built-in accelerometer can provide accurate and repeatable measurements of walking in children with unilateral spastic cerebral palsy.

Thirty-five children aged 6 to 12 years will complete two walking trials along a 10-meter indoor walkway at their usual comfortable speed. During each trial, a smartphone will be secured over the lower back at the L4-L5 level to record body acceleration using the Phyphox application. At the same time, a video camera will record the child's walking for analysis using Kinovea software.

Measurements obtained from the smartphone will be compared with measurements obtained from video analysis. The study will assess walking velocity, cadence, stride timing, and gait asymmetry. The two repeated walking trials will also be used to determine whether the smartphone measurements are consistent when the test is repeated during the same session.

The study does not involve any treatment or change to the child's usual medical or physical therapy care. The purpose is to determine whether smartphone-based gait assessment may be a practical, low-cost method for evaluating walking in children with unilateral spastic cerebral palsy.

Read the detailed description

Children with unilateral spastic cerebral palsy may have differences in walking speed, step timing, cadence, and symmetry between the affected and unaffected lower limbs. Instrumented gait laboratories can provide detailed gait measurements, but they may be expensive, time-consuming, or unavailable in many clinical settings. Smartphones contain built-in motion sensors that may offer a simpler and more accessible method of measuring gait.

This methodological validation study will examine the concurrent validity and intra-session test-retest reliability of smartphone-embedded linear accelerometry for the assessment of spatiotemporal gait parameters in children with unilateral spastic cerebral palsy.

A convenience sample of 35 children will be recruited from the Deraya University outpatient clinic. Eligible participants will be 6 to 12 years of age, have a clinical diagnosis of unilateral spastic cerebral palsy, and be classified as Gross Motor Function Classification System level I or II.

Each participant will attend one assessment session. A Samsung Galaxy A7 smartphone will be secured horizontally over the lower back at the L4-L5 vertebral level using an adjustable waist belt. This location is intended to approximate the body's center of mass. The smartphone's internal linear accelerometer will record movement data using the Phyphox application.

Participants will walk at a comfortable, self-selected speed along a flat, unobstructed 10-meter indoor walkway. At the same time, a high-definition video camera mounted on a stable tripod will record the walking trial from a perpendicular distance of approximately 3 meters. The video recordings will be analyzed frame by frame using Kinovea software and will serve as the reference method.

Each child will complete two identical walking trials during the same session. The trials will be separated by a seated rest period of approximately 5 to 10 minutes to reduce fatigue. No therapeutic intervention will be administered, and the child's usual medical or physical therapy care will not be changed.

Data obtained from the smartphone accelerometer and the video analysis will be used to calculate walking velocity, cadence, stride timing, and gait asymmetry. Smartphone-derived measurements will be compared with the corresponding Kinovea-derived measurements to evaluate concurrent validity. Measurements from the first and second walking trials will also be compared to evaluate intra-session test-retest reliability.

The study is intended to determine whether smartphone-based accelerometry can provide valid and repeatable gait measurements that may be useful as a practical, non-invasive, and low-cost clinical assessment method for children with unilateral spastic cerebral palsy.

03

Conditions studied

  • Cerebral Palsy
  • Unilateral Spastic Cerebral Palsy

Browse trials for

Keywords

  • Smartphone Accelerometry
  • Gait Analysis
  • Spatiotemporal Gait Parameters
  • Unilateral Spastic Cerebral Palsy
  • Hemiplegic Cerebral Palsy
04

Who can participate

Ages eligible
6 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

A convenience sample of children aged 6 to 12 years with a clinical diagnosis of unilateral spastic cerebral palsy will be recruited from the Deraya University outpatient clinic. Eligible participants will be classified as Gross Motor Function Classification System level I or II and must be able to walk independently for 10 meters without physical assistance or handheld mobility aids. Participants must also be able to understand and follow simple verbal instructions required for gait assessment.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Clinical diagnosis of unilateral spastic cerebral palsy.
  2. Chronological age ranging from 6 to 12 years.
  3. Gross Motor Function Classification System (GMFCS) Level I or II (capable of walking 10 meters independently without physical support or handheld mobility aids).
  4. Ability to comprehend and execute simple verbal instructions during clinical evaluation.

Exclusion criteria

Exclusion criteria:

  1. History of lower extremity corrective orthopedic surgery or joint casting within the preceding 12 months.
  2. Botulinum Toxin Type A injections administered to the lower limbs within the past 6 months.
  3. Fixed structural bony deformities or rigid joint contractures in the lower extremities.
  4. Severe, uncorrected visual or auditory deficits that threaten safety or test execution
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
35 participants (estimated)
Patient registry
No

Groups and cohorts

  • Children With Unilateral Spastic Cerebral Palsy

    A convenience sample of 35 children aged 6 to 12 years with unilateral spastic cerebral palsy and Gross Motor Function Classification System levels I or II. All participants will complete two 10-meter walking trials while smartphone accelerometry and simultaneous 2-dimensional video gait analysis are performed. No treatment will be assigned or modified.

    Diagnostic Test: Smartphone-Embedded Gait Assessment

Interventions

  • Diagnostic testSmartphone-Embedded Gait Assessment

    A Samsung Galaxy A7 smartphone will be secured horizontally over the participant's lower back at the L4-L5 vertebral level using an adjustable waist belt. The smartphone's built-in linear accelerometer and the Phyphox application will record movement during two 10-meter walking trials performed at a comfortable, self-selected speed. Simultaneous video recordings will be analyzed using Kinovea software as the reference method. Walking velocity, cadence, stride timing, and gait asymmetry will be calculated. The two trials will be separated by a seated rest period of 5 to 10 minutes.

06

What researchers measure

Primary outcomes

  1. Walking Velocity Measured by Smartphone Accelerometry

    Walking velocity, expressed in meters per second, will be calculated by dividing the 10-meter walking distance by the time required to complete the walkway. Velocity derived from smartphone linear accelerometry using the Phyphox application will be compared with velocity obtained from frame-by-frame 2-dimensional video analysis using Kinovea software.

    Time frame: Baseline

  2. Cadence Measured by Smartphone Accelerometry

    Cadence, expressed as steps per minute, will be calculated from acceleration peak intervals recorded by the smartphone using the Phyphox application. Smartphone-derived cadence will be compared with cadence determined by visual frame-by-frame analysis of the simultaneous Kinovea video recording.

    Time frame: Baseline

  3. Gait Asymmetry Index

    The Gait Asymmetry Index will be calculated using temporal gait data from the affected and unaffected lower limbs. The index will quantify the degree of asymmetry between the two sides. Smartphone-derived asymmetry values will be compared with values obtained from the simultaneous Kinovea video analysis. Higher values indicate greater gait asymmetry.

    Time frame: Baseline

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Schow, E., Bugge, C., & Jensen, K. (2014). Trunk accelerometry using a smartphone for standard clinical gait evaluation: A reliability study. Journal of NeuroEngineering and Rehabilitation, 11(1), 37.
  • Plotnik M, Giladi N, Hausdorff JM. A new measure for quantifying the bilateral coordination of human gait: effects of aging and Parkinson's disease. Exp Brain Res. 2007 Aug;181(4):561-70. doi: 10.1007/s00221-007-0955-7. Epub 2007 May 15. PubMed 17503027 ↗
  • Fernández-González, P., Carratalá-Tejada, M., Monge-Pereira, E., & Miangolarra-Page, J. C. (2020). Reliability and validation of 2D video analysis using Kinovea software for assessment of spatiotemporal gait parameters. Medical Engineering & Physics, 78, 45-51.
  • Almqvist, L., & Riad, J. (2020). Accelerometer-based gait analysis in children with cerebral palsy: Validation and clinical utility of spatiotemporal parameters. Developmental Medicine & Child Neurology, 62(7), 834-840.
  • Silsupadol P, Teja K, Lugade V. Reliability and validity of a smartphone-based assessment of gait parameters across walking speed and smartphone locations: Body, bag, belt, hand, and pocket. Gait Posture. 2017 Oct;58:516-522. doi: 10.1016/j.gaitpost.2017.09.030. Epub 2017 Sep 23. PubMed 28961548 ↗
  • Balsalobre-Fernandez C, Tejero-Gonzalez CM, del Campo-Vecino J, Bavaresco N. The concurrent validity and reliability of a low-cost, high-speed camera-based method for measuring the flight time of vertical jumps. J Strength Cond Res. 2014 Feb;28(2):528-33. doi: 10.1519/JSC.0b013e318299a52e. PubMed 23689339 ↗
  • Staacks, S., Hütz, S., Heinke, H., & Stampfer, J. (2018). Advanced smartphone-based experiments with phyphox. Physics Education, 53(4), 045009.

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jul 2026 (actual). Primary completion is estimated for Nov 2026, 4 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 16, 2026
First posted
Jul 28, 2026
StartActual
Jul 1, 2026
Primary completionEst.
Nov 1, 2026
CompletionEst.
Dec 1, 2026
Last update
Jul 28, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 28, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07730086
Lead sponsor
Deraya University
Responsible party
Sponsor
First posted
Jul 28, 2026
Start date
Jul 1, 2026
Primary completion
Nov 1, 2026 (estimated)
Completion
Dec 1, 2026 (estimated)
Last update
Jul 28, 2026

Study contacts

Shereen Ali Amin
Contact
Shereen.ali@deraya.edu.eg
01112929145 ext. +20

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion